Trulieve Cannabis (TRLV) Common Equity (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Common Equity for 7 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Common Equity fell 5.71% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 5.71% YoY), while the FY2025 annual figure was $1.1 billion, down 8.49% from the prior year.
• Common Equity came in at $1.1 billion for Q1 2026 at Trulieve Cannabis, up from $1.1 billion in the prior quarter.
• The five-year high for Common Equity was $2.1 billion in Q2 2022, with the low at $1.1 billion in Q4 2025.
• Average Common Equity over 5 years is $1.5 billion, with a median of $1.4 billion recorded in 2024.
• Across the five-year window, Common Equity surged 336.42% in 2022 and sank 31.04% in 2023, its largest moves.
• Year by year, Common Equity stood at $1.9 billion in 2022, then fell by 26.93% to $1.4 billion in 2023, then declined by 11.33% to $1.2 billion in 2024, then decreased by 8.49% to $1.1 billion in 2025, then increased by 0.55% to $1.1 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $1.1 billion, $1.1 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.